BREAKING: An independent FDA advisory panel has voted to authorize Johnson & Johnson Covid-19 vaccine boosters to all J&J recipients 18 and older.
David Zalubowski/AP, FILE
For the two mRNA vaccines, the panel agreed they should be authorized for a narrower group: seniors and everyone 18 or older if they have underlying conditions or could be exposed to the virus at work. They also agreed on a timeline of 6 months post second shot. Experts on the FDA panel were quick to highlight that success, emphasizing that the conversation around boosters should not overshadow the vital campaign to get the 66 million unvaccinated Americans vaccinated.
Another pertinent debate that the FDA panel will take on Friday is the potential benefits of mixing and matching vaccines for booster shots. Many J&J recipients who feel the single-shot vaccine didn’t perform as well as the mRNA vaccines have been clamoring for data on their options for switching.found that boosting with a shot different from what people got the first time appears to be safe and effective.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
COVID-19 Live Updates: FDA to vote on Johnson & Johnson vaccine booster shot after Moderna approvedAn FDA expert panel will vote on whether to support or oppose a booster shot for the Johnson & Johnson COVID-19 vaccine. Follow Newsweek's liveblog for all the latest.
Baca lebih lajut »
Independent FDA panel votes to authorize Moderna booster for seniors and high-risk AmericansBREAKING: An independent FDA advisory panel voted unanimously to authorize Moderna Covid-19 vaccine boosters for Americans 65 and older, anyone 18 and older with underlying conditions and those frequently exposed to the virus.
Baca lebih lajut »
FDA panel debates lower-dose Moderna COVID shots for boosterU.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot -- this time, using half the original dose. Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand.
Baca lebih lajut »
FDA panel endorses lower-dose Moderna COVID shot for boosterU.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19.
Baca lebih lajut »
FDA panel unanimously endorses Moderna boosters for certain populationsMembers of the Food and Drug Administration’s vaccine expert panel on Thursday endorsed boosters for Moderna recipients who are at high risk of severe COVID-19, occupational exposure to COVID-19 or are 65 years and older.Why it matters: The unanimous decision mirrors the FDA conditions for those who qualify for a Pfizer booster.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeBe smart: Despite small data sample sizes and limited data, the agency
Baca lebih lajut »